416 related articles for article (PubMed ID: 20307764)
1. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
Lazarovici TS; Yahalom R; Taicher S; Schwartz-Arad D; Peleg O; Yarom N
J Oral Maxillofac Surg; 2010 Apr; 68(4):790-6. PubMed ID: 20307764
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonates and dental implants.
McLeod NM
J Oral Maxillofac Surg; 2009 Jun; 67(6):1355. PubMed ID: 19446233
[No Abstract] [Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
Lazarovici TS; Yahalom R; Taicher S; Elad S; Hardan I; Yarom N
J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045
[TBL] [Abstract][Full Text] [Related]
5. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
Chu V; ;
Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
[TBL] [Abstract][Full Text] [Related]
6. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
Goss A; Bartold M; Sambrook P; Hawker P
J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
8. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.
Holzinger D; Seemann R; Matoni N; Ewers R; Millesi W; Wutzl A
J Oral Maxillofac Surg; 2014 Oct; 72(10):1937.e1-8. PubMed ID: 25234534
[TBL] [Abstract][Full Text] [Related]
9. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
[TBL] [Abstract][Full Text] [Related]
10. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
Epstein MS; Wicknick FW; Epstein JB; Berenson JR; Gorsky M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):593-6. PubMed ID: 20955948
[TBL] [Abstract][Full Text] [Related]
11. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
[TBL] [Abstract][Full Text] [Related]
12. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Chiu CT; Chiang WF; Chuang CY; Chang SW
J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for bisphosphonate-related osteonecrosis of the jaws.
Fleisher KE; Glickman RS
J Oral Maxillofac Surg; 2011 Apr; 69(4):959; author reply 959-60. PubMed ID: 21440820
[No Abstract] [Full Text] [Related]
14. Bisphosphonate therapy and dental treatment.
Phillips G
J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
[No Abstract] [Full Text] [Related]
15. Osteonecrosis of the jaw.
Reilly MM; Moore S
Oncology (Williston Park); 2008 Feb; 22(2 Suppl Nurse Ed):39-41. PubMed ID: 18431898
[No Abstract] [Full Text] [Related]
16. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
Naik NH; Russo TA
Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
[TBL] [Abstract][Full Text] [Related]
18. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
Bedogni A; Bettini G; Totola A; Saia G; Nocini PF
J Oral Maxillofac Surg; 2010 Jul; 68(7):1662-6. PubMed ID: 20561470
[TBL] [Abstract][Full Text] [Related]
19. [Diabetes mellitus and bisphosphonate-related osteonecrosis of the jaws].
Urade M
Clin Calcium; 2009 Sep; 19(9):1332-8. PubMed ID: 19721206
[TBL] [Abstract][Full Text] [Related]
20. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
